These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 32448054)
1. Biomolecular interactions and binding dynamics of tyrosine kinase inhibitor erdafitinib, with human serum albumin. Amir M; Qureshi MA; Javed S J Biomol Struct Dyn; 2021 Jul; 39(11):3934-3947. PubMed ID: 32448054 [TBL] [Abstract][Full Text] [Related]
2. Exploring the combination characteristics of lumefantrine, an antimalarial drug and human serum albumin through spectroscopic and molecular docking studies. Musa KA; Ridzwan NFW; Mohamad SB; Tayyab S J Biomol Struct Dyn; 2021 Feb; 39(2):691-702. PubMed ID: 31913089 [TBL] [Abstract][Full Text] [Related]
3. Elucidation of binding dynamics of tyrosine kinase inhibitor tepotinib, to human serum albumin, using spectroscopic and computational approach. Amir M; Javed S Int J Biol Macromol; 2023 Jun; 241():124656. PubMed ID: 37119913 [TBL] [Abstract][Full Text] [Related]
4. Biomolecular interaction mechanism of an anticancer drug, pazopanib with human serum albumin: a multi-spectroscopic and computational approach. Kandandapani S; Kabir MZ; Ridzwan NFW; Mohamad SB; Tayyab S J Biomol Struct Dyn; 2022 Nov; 40(18):8312-8323. PubMed ID: 33870854 [TBL] [Abstract][Full Text] [Related]
5. Understanding the binding of quinoline amines with human serum albumin by spectroscopic and induced fit docking methods. Vennila KN; Elango KP J Biomol Struct Dyn; 2019 Jul; 37(11):2753-2765. PubMed ID: 30052140 [TBL] [Abstract][Full Text] [Related]
6. Characterizing the interaction between pyrogallol and human serum albumin by spectroscopic and molecular docking methods. Roufegarinejad L; Amarowicz R; Jahanban-Esfahlan A J Biomol Struct Dyn; 2019 Jul; 37(11):2766-2775. PubMed ID: 30052121 [TBL] [Abstract][Full Text] [Related]
7. Spectroscopic methodologies and computational simulation studies on the characterization of the interaction between human serum albumin and astragalin. Lyu S; Wang W J Biomol Struct Dyn; 2021 May; 39(8):2959-2970. PubMed ID: 32306829 [TBL] [Abstract][Full Text] [Related]
8. Evaluating the biomolecular interaction between delamanid/formulations and human serum albumin by fluorescence, CD spectroscopy and SPR: Effects on protein conformation, kinetic and thermodynamic parameters. Tongkanarak K; Loupiac C; Neiers F; Chambin O; Srichana T Colloids Surf B Biointerfaces; 2024 Jul; 239():113964. PubMed ID: 38761495 [TBL] [Abstract][Full Text] [Related]
9. Exploring the interaction between tyrphostin 9 and human serum albumin using biophysical and computational methods. Kandandapani S; Ridzwan NFW; Mohamad SB; Tayyab S J Biomol Struct Dyn; 2020 Sep; 38(14):4134-4142. PubMed ID: 31552810 [TBL] [Abstract][Full Text] [Related]
10. Interaction and photo-induced cleavage studies of meropenem drug with human serum albumin using spectroscopic and molecular docking investigations. Abdo Esmail SA; Shamsi M; Al-Asbahy WM J Biomol Struct Dyn; 2019 Aug; 37(12):3282-3289. PubMed ID: 30088794 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive views toward the biomolecular recognition of an anticancer drug, leflunomide with human serum albumin. Kabir MZ; Tayyab H; Erkmen C; Mohamad SB; Uslu B J Biomol Struct Dyn; 2024 Sep; 42(14):7257-7271. PubMed ID: 37529911 [TBL] [Abstract][Full Text] [Related]
12. Interaction of a tyrosine kinase inhibitor, vandetanib with human serum albumin as studied by fluorescence quenching and molecular docking. Kabir MZ; Feroz SR; Mukarram AK; Alias Z; Mohamad SB; Tayyab S J Biomol Struct Dyn; 2016 Aug; 34(8):1693-704. PubMed ID: 26331959 [TBL] [Abstract][Full Text] [Related]
13. Biomolecular interaction of a platelet aggregation inhibitor, 3,4-methylenedioxy-β-nitrostyrene with human serum albumin: multi-spectral and computational characterization. Kabir MZ; Roslan AA; Ridzwan NFW; Mohamad SB; Tayyab S J Biomol Struct Dyn; 2020 Jun; 38(9):2693-2703. PubMed ID: 31271347 [TBL] [Abstract][Full Text] [Related]
14. Unraveling the binding behavior of the antifouling biocide 4,5-dichloro-2-n-octyl-4-isothiazolin-3-one with human serum albumin: Multi-spectroscopic, atomic force microscope, computational simulation, and esterase activity. Zhou J; Li J; Cheng C; Yao Y; Li Y; Liu H; Wu L Int J Biol Macromol; 2024 Aug; 274(Pt 1):133266. PubMed ID: 38906347 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the binding mechanism for a water-soluble Pd(II) complex containing β-amino alcohols with HSA applying experimental and computational methods. Shahabadi N; Ghaffari L; Mardani Z; Hadidi S J Biomol Struct Dyn; 2024 Apr; 42(7):3790-3801. PubMed ID: 37243704 [TBL] [Abstract][Full Text] [Related]
17. Multispectroscopic insight, morphological analysis and molecular docking studies of Cu Yousuf I; Bashir M; Arjmand F; Tabassum S J Biomol Struct Dyn; 2019 Aug; 37(12):3290-3304. PubMed ID: 30124142 [TBL] [Abstract][Full Text] [Related]
18. Spectroscopy and molecular docking approach for investigation on the binding of nocodazole to human serum albumin. Singh I; Luxami V; Paul K Spectrochim Acta A Mol Biomol Spectrosc; 2020 Jul; 235():118289. PubMed ID: 32222625 [TBL] [Abstract][Full Text] [Related]
19. Shedding light on the bimolecular interactions of Cafaminol and human serum albumin: spectroscopic characterization and in-silico investigation. Parvizi N; Mohammad-Aghaie D; Soltani Rad MN; Behrouz S; Alavianmehr MM J Biomol Struct Dyn; 2022 Jul; 40(11):4893-4904. PubMed ID: 33390094 [TBL] [Abstract][Full Text] [Related]
20. Deciphering the binding of carbendazim (fungicide) with human serum albumin: A multi-spectroscopic and molecular modelling studies. Siddiqui MF; Khan MS; Husain FM; Bano B J Biomol Struct Dyn; 2019 Jun; 37(9):2230-2241. PubMed ID: 30047309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]